Skip to main content

Alternative epinephrine delivery method during anaphylaxis for pediatric patients

This project has been secured to protect intellectual property.

Login for More Information

Development of a sublingual tablet that replaces the epi pen as a treatment for anaphylaxis

Project Overview

Anaphylaxis is a fatal allergic reaction if it is left untreated. The current method for treating anaphylaxis is an epinephrine auto injector. These auto injectors are rising in costs therefore, a different delivery method that is less expensive would make treating anaphylaxis more accessible. A tablet that will be delivered sublingually will provide a cheaper alternative to the novel epinephrine auto injector as the blood vessels underneath the tongue are vast and may provide a faster route for epinephrine into the bloodstream of the patient.

Contact Information

Team Members

  • Poorva Halbe - Team Leader & Co-BWIG
  • Christopher Pudzisz - Communicator & BSAC
  • Nicholas Jacobson - Co-BWIG & BPAG

Advisor and Client

  • Prof. Paul Campagnola - Advisor
  • Dr. Lenard Markman - Client

Related Projects

Back to Top